Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Oncotarget|February 10, 2018
Individual and combined effect of TP53, MDM2, MDM4, MTHFR, CCR5, and CASP8 gene polymorphisms in lung cancerAusra Stumbryte, Zivile Gudleviciene, Gabrielis Kundrotas, et al.
Medicina (Kaunas, Lithuania)|January 5, 2005
[Hypotensive epidural anesthesia in thoracic surgery]Renatas Tikuisis, Povilas Miliauskas, Aleksas Zurauskas, et al.
Medicina (Kaunas, Lithuania)|February 1, 2003
[Bronchoplastic operations for lung cancer]Saulius Cicenas, Pranciskus Naujokaitis, Algirdas Jackevicius, et al.
Medicina (Kaunas, Lithuania)|April 14, 2004
[Intercostal nerve blockade with alcohol during operation for postthoracotomy pain]Povilas Miliauskas, Saulius Cicenas, Renatas Tikuisis, et al.
Medicina (Kaunas, Lithuania)|January 5, 2005
[Prognostic factors for resectable esophageal cancer]Aleksas Zurauskas, Povilas Miliauskas, Renatas Tikuisis, et al.
International Medical Case Reports Journal|June 12, 2013
Extralobar pulmonary sequestrationAlbertas Ulys, Narimantas Evaldas Samalavicius, Saulius Cicenas, et al.
Oncotargets and Therapy|November 19, 2024
Prognostic Value of miR-10a-3p in Non-Small Cell Lung Cancer PatientsJulija Simiene, Linas Kunigenas, Rimvile Prokarenkaite, et al.
Medicina (Kaunas, Lithuania)|April 14, 2004
[Surgery for esophageal cancer: 10 years experience]Saulius Cicenas, Eugenijus Stratilatovas, Povilas Miliauskas, et al.
BMC Cancer|September 11, 2023
Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLCJulija Simiene, Daiva Dabkeviciene, Diana Stanciute, et al.
The Lancet. Oncology|January 27, 2012
Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 studyTudor Ciuleanu, Lilia Stelmakh, Saulius Cicenas, et al.
Pageof 5